MedPath

Randomized crossover trial of mandibular single-implant overdenture: patient-reported outcome and cost-effectiveness

Not Applicable
Conditions
Completely mandibular edentulous arch
Registration Number
JPRN-UMIN000017883
Lead Sponsor
Tokyo Medical and Dental University
Brief Summary

implant survival rate 95.5%

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
21
Inclusion Criteria

Not provided

Exclusion Criteria

current use of bisphosphonate administration. Having a history of head and neck radiation. Having heavy systemic disorders. Heavy smokers. Having infections. Undergoing radiation therapy and chemotherapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath